Company Legal Name
Latest Valuation
Founded Year
Headquarter
Alloy Therapeutics operates a comprehensive drug discovery platform specializing in antibody, T-cell receptor (TCR) mimic, and oligonucleotide therapeutics development. Founded in 2017 and headquartered in Boston, the company provides integrated discovery services that span from target identification through lead optimization. Alloy's platform combines proprietary technologies with established methodologies to accelerate therapeutic development timelines for pharmaceutical partners and internal programs. The company's multidisciplinary approach addresses critical bottlenecks in drug discovery across multiple therapeutic modalities. Alloy continues to expand its platform capabilities while building a diverse pipeline of novel therapeutic candidates, positioning itself as a strategic partner for biopharmaceutical companies seeking efficient drug discovery solutions.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Alloy Therapeutics pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Alloy Therapeutics ?
The latest valuation of Alloy Therapeutics is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Alloy Therapeutics ?
The minimum investment is $10, enabling fractionalized access to Alloy Therapeutics pre-IPO shares.
What fees will I pay when investing in Alloy Therapeutics pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Alloy Therapeutics pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Alloy Therapeutics pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.